Skip to content
8-K

Material Event

Acrivon Therapeutics, Inc. ACRV

0001193125-26-274410

← back to feed
Filed
Jun 17, 2026 5:28 PM ET
Period of report
—

What happened

  • 5.02 Departure/Election of Directors or Officers
  • 5.07 Other reported item
  • 9.01 Financial Statements & Exhibits

On SEC.gov

Primary document ↗ Inline XBRL ↗ Filing index ↗

Financials in this filing

Structured financials aren't available for this filing — it may be an event-driven form (8-K/6-K), pre-date XBRL (~2009), or report only narrative content. Use the SEC.gov links above to read it.